Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsCalithera Biosciences, Inc. announced that it has enrolled the first patient in a Phase II clinical trial of sapanisertib in patients with NFE2L2-mutated squamous NSCLC.
[Calithera Biosciences, Inc.]
Home Newsletters Calithera Biosciences Announces First Patient Enrolled in Phase II Clinical Trial of...
